Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Breaking News
Iran's President Raisi confirmed dead in helicopter crash
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about gene therapy
Recent news which mentions gene therapy
< Previous
1
2
3
Next >
FDA Gives Green Signal To Pfizer's Duchenne Gene Therapy Trial
April 28, 2022
Tickers
PFE
Tags
gene therapy
Health Care
Benzinga
From
Benzinga
Monitoring Board Gives Positive Recommendation On Ocugen's Eye Disease Gene Therapy Trial
April 25, 2022
Tickers
OCGN
Tags
Penny Stocks
Small Cap
Biotech
From
Benzinga
Creative Biolabs Announces Sponsorship and Exhibition at PEGS Boston 2022
April 21, 2022
Tags
gene therapy
antibody
cell therapy
From
PRUnderground
Amicus Shares Encouraging Long-Term Data Of AT-GAA Study In Pompe Disease
March 16, 2022
Tickers
FOLD
Tags
Benzinga
Movers
General
From
Benzinga
FDA Recommends At Least 15 years Of Follow-Up For Genome Editing Product Trials
March 15, 2022
Tickers
BLUE
NTLA
Tags
Penny Stocks
Small Cap
NTLA
From
Benzinga
Why Bluebird Bio Shares Are Tumbling Today
March 07, 2022
Tickers
BLUE
Tags
News
General
Movers
From
Benzinga
Gene Therapy Player Amicus Therapeutics Terminates SPAC Merger, Shares Fall
February 24, 2022
Tickers
ARYD
FOLD
Tags
Trading Ideas
Earnings
ARYD
From
Benzinga
Takeda Inks $2B Gene Therapy Pact With Code Biotherapeutics
February 22, 2022
Tickers
TAK
TKPHF
Tags
Health Care
Contracts
gene therapy
From
Benzinga
FDA Asks For More Data To Resolve BioMarin's Gene Therapy Clinical Hold
February 18, 2022
Tickers
BMRN
Tags
gene therapy
Health Care
BMRN
From
Benzinga
RegenXBio Posts Updated Data From Hunter Syndrome Gene Therapy Trial
February 09, 2022
Tickers
RGNX
Tags
Benzinga
Briefs
News
From
Benzinga
After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data
February 09, 2022
Tickers
AVRO
Tags
News
General
Benzinga
From
Benzinga
Sangamo Therapeutics Shares Updated Interim Data From Fabry Disease Gene Therapy Trial
February 08, 2022
Tickers
SGMO
Tags
Small Cap
Market News
Biotech
From
Benzinga
Sio Gene Terminates Parkinson's Gene Therapy Pact With Oxford Biomedica, Announces CEO Transition
February 01, 2022
Tickers
SIOX
Tags
News
Briefs
General
From
Benzinga
Taysha Reports Efficacy, Safety Data From High Dose Cohort For Neurological Disorder Gene Therapy Trial
January 31, 2022
Tickers
TSHA
Tags
gene therapy
Biotech
Market News
From
Benzinga
Taysha Gene Plans Protocol Amendment After Patient Death In Gene Therapy Trial
January 27, 2022
Tickers
TSHA
Tags
Market News
Biotech
Phase 1 Trial
From
Benzinga
FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder
January 25, 2022
Tickers
FBIO
MBIO
Tags
Benzinga
General
FDA
From
Benzinga
FDA Pushes Review Period For Bluebird bio's Neurodegenerative Disease, Thalassemia Gene Therapies
January 18, 2022
Tickers
BLUE
Tags
Benzinga
Briefs
News
From
Benzinga
Sarepta Abandons Lysogene-Partnered Pivotal-Stage Gene Therapy Candidate
January 13, 2022
Tickers
SRPT
Tags
Health Care
Contracts
Market News
From
Benzinga
Bluebird bio Lays Out Planned Updates Ahead Of J.P. Morgan Healthcare Conference
January 11, 2022
Tickers
BLUE
Tags
gene therapy
why it's moving
Health Care
From
Benzinga
BioMarin's Hemophilia Gene Therapy Meets Efficacy Endpoints At Two Year Analysis
January 10, 2022
Tickers
BMRN
Tags
gene therapy
BMRN
Health Care
From
Benzinga
Pfizer's Duchenne Gene Therapy Trial Put On FDA Hold After Patient Death
December 21, 2021
Tickers
PFE
Tags
gene therapy
Health Care
Benzinga
From
Benzinga
Adverum Outlines Development Plan For ADVM-022 Gene Therapy In Wet AMD
December 21, 2021
Tickers
ADVM
Tags
Penny Stocks
Market News
Biotech
From
Benzinga
Why Are Bluebird Bio Shares Trading Lower Today?
December 20, 2021
Tickers
BLUE
Tags
News
Briefs
FDA
From
Benzinga
Bluebird bio's Neurodegenerative Disease Gene Therapy Under Priority FDA Review, Despite Clinical Hold
December 20, 2021
Tickers
BLUE
Tags
Small Cap
Biotech
Market News
From
Benzinga
UniQure Shares Fall After Clinical Update From Huntington's Disease Gene Therapy Trial
December 16, 2021
Tickers
QURE
Tags
Briefs
News
General
From
Benzinga
New Data At ASH21 Show Bluebird's Thalassemia Gene Therapy Potentially Curative One-Time Treatment
December 13, 2021
Tickers
BLUE
Tags
Biotech
Market News
BLUE
From
Benzinga
Bluebird Bio Posts Updated Data From Sickle Cell Gene Therapy Program
December 13, 2021
Tickers
BLUE
Tags
Briefs
News
General
From
Benzinga
Selecta's Gene Therapy Trial For Genetic Metabolic Disorder Put On FDA Hold
November 26, 2021
Tickers
SELB
Tags
Phase 1 Trial
Trading Ideas
Biotech
From
Benzinga
Spark Therapeutics' Hemophilia Gene Therapy Shows Reduction In Bleeding Episodes
November 18, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBF
Market News
Biotech
From
Benzinga
Braeden Lichti - Investing in Precision Medicine to Yield New Treatments for Neurodegenerative Diseases
November 18, 2021
Tags
Canada
Biotech
Banking
From
PRLog
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.